BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26289723)

  • 1. Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis.
    Frederix I; Hansen D; Coninx K; Vandervoort P; Vandijck D; Hens N; Van Craenenbroeck E; Van Driessche N; Dendale P
    Eur J Prev Cardiol; 2016 May; 23(7):674-82. PubMed ID: 26289723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits.
    Frederix I; Solmi F; Piepoli MF; Dendale P
    Eur J Prev Cardiol; 2017 Nov; 24(16):1708-1717. PubMed ID: 28925749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Utility Analysis of a Cardiac Telerehabilitation Program: The Teledialog Project.
    Kidholm K; Rasmussen MK; Andreasen JJ; Hansen J; Nielsen G; Spindler H; Dinesen B
    Telemed J E Health; 2016 Jul; 22(7):553-63. PubMed ID: 26713491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial.
    Brouwers RW; Kraal JJ; Traa SC; Spee RF; Oostveen LM; Kemps HM
    BMC Cardiovasc Disord; 2017 Jan; 17(1):46. PubMed ID: 28143388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Utility Analysis of Home-Based Telerehabilitation Compared With Centre-Based Rehabilitation in Patients With Heart Failure.
    Hwang R; Morris NR; Mandrusiak A; Bruning J; Peters R; Korczyk D; Russell T
    Heart Lung Circ; 2019 Dec; 28(12):1795-1803. PubMed ID: 30528811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands.
    Brouwers RWM; van der Poort EKJ; Kemps HMC; van den Akker-van Marle ME; Kraal JJ
    JAMA Netw Open; 2021 Dec; 4(12):e2136652. PubMed ID: 34854907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium - a cost-benefit analysis.
    Frederix I; Vandijck D; Hens N; De Sutter J; Dendale P
    Acta Cardiol; 2018 Jun; 73(3):222-229. PubMed ID: 28799460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?
    Scherrenberg M; Zeymer U; Schneider S; Van der Velde AE; Wilhelm M; Van't Hof AWJ; Kolkman E; Prins LF; Prescott E; Iliou MC; Peña-Gil C; Ardissino D; De Kluiver EP; Dendale P
    Int J Cardiol; 2021 Oct; 340():1-6. PubMed ID: 34419529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.
    Bailly L; Mossé P; Diagana S; Fournier M; d'Arripe-Longueville F; Diagana O; Gal J; Grebet J; Moncada M; Domerego JJ; Radel R; Fabre R; Fuch A; Pradier C
    BMC Cardiovasc Disord; 2018 Dec; 18(1):225. PubMed ID: 30522438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial.
    Frederix I; Hansen D; Coninx K; Vandervoort P; Vandijck D; Hens N; Van Craenenbroeck E; Van Driessche N; Dendale P
    J Med Internet Res; 2015 Jul; 17(7):e185. PubMed ID: 26206311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of exercise-based cardiac rehabilitation in patients with a recent acute coronary syndrome.
    Hautala AJ; Kiviniemi AM; Mäkikallio T; Koistinen P; Ryynänen OP; Martikainen JA; Seppänen T; Huikuri HV; Tulppo MP
    Scand J Med Sci Sports; 2017 Nov; 27(11):1395-1403. PubMed ID: 27541076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N; Au HJ; Tu D; O'Callaghan CJ; Isogai PK; Karapetis CS; Zalcberg JR; Evans WK; Moore MJ; Siddiqui J; Findlay B; Colwell B; Simes J; Gibbs P; Links M; Tebbutt NC; Jonker DJ; ;
    J Natl Cancer Inst; 2009 Sep; 101(17):1182-92. PubMed ID: 19666851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform.
    Claes J; Buys R; Woods C; Briggs A; Geue C; Aitken M; Moyna N; Moran K; McCaffrey N; Chouvarda I; Walsh D; Budts W; Filos D; Triantafyllidis A; Maglaveras N; Cornelissen VA
    BMJ Open; 2017 Jun; 7(6):e016781. PubMed ID: 28667228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
    Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
    Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study.
    Kraal JJ; Van den Akker-Van Marle ME; Abu-Hanna A; Stut W; Peek N; Kemps HM
    Eur J Prev Cardiol; 2017 Aug; 24(12):1260-1273. PubMed ID: 28534417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of telerehabilitation versus traditional care after total hip replacement: A trial-based economic evaluation.
    Nelson M; Russell T; Crossley K; Bourke M; McPhail S
    J Telemed Telecare; 2021 Jul; 27(6):359-366. PubMed ID: 31530065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Chew DS; Li Y; Zeitouni M; Whellan DJ; Kitzman D; Mentz RJ; Duncan P; Pastva AM; Reeves GR; Nelson MB; Chen H; Reed SD
    JAMA Cardiol; 2022 Feb; 7(2):140-148. PubMed ID: 34817542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis.
    Senanayake S; Halahakone U; Abell B; Kularatna S; McCreanor V; McPhail SM; Redfern J; Tom Briffa ; Parsonage W
    BMC Health Serv Res; 2023 May; 23(1):512. PubMed ID: 37208666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telerehab III: a multi-center randomized, controlled trial investigating the long-term effectiveness of a comprehensive cardiac telerehabilitation program--rationale and study design.
    Frederix I; Hansen D; Coninx K; Vandervoort P; Van Craenenbroeck EM; Vrints C; Dendale P
    BMC Cardiovasc Disord; 2015 May; 15():29. PubMed ID: 25948479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.